TULIFTA Trademark

Trademark Overview

On Wednesday, August 14, 2019, a trademark application was filed for TULIFTA with the United States Patent and Trademark Office. The USPTO has given the TULIFTA trademark a serial number of 88578191. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 21, 2022. This trademark is owned by Impel NeuroPharma, Inc.. The TULIFTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and alleviation of migraine headaches
tulifta

General Information

Serial Number88578191
Word MarkTULIFTA
Filing DateWednesday, August 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 21, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and alleviation of migraine headaches

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImpel NeuroPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NameImpel NeuroPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Monday, March 21, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 21, 2022ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 16, 2021EXTENSION 3 GRANTED
Monday, August 16, 2021EXTENSION 3 FILED
Monday, August 16, 2021TEAS EXTENSION RECEIVED
Saturday, January 23, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 21, 2021EXTENSION 2 GRANTED
Thursday, January 21, 2021EXTENSION 2 FILED
Thursday, January 21, 2021TEAS EXTENSION RECEIVED
Saturday, August 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 30, 2020EXTENSION 1 GRANTED
Thursday, July 30, 2020EXTENSION 1 FILED
Thursday, July 30, 2020TEAS EXTENSION RECEIVED
Tuesday, April 28, 2020CORRECTED NOA E-MAILED
Monday, April 27, 2020NOTICE OF ALLOWANCE CORRECTION ENTERED
Thursday, April 23, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 25, 2020TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, February 18, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 24, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 24, 2019PUBLISHED FOR OPPOSITION
Wednesday, December 4, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 14, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, November 14, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, August 17, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

tulifta migraine headaches alleviation treatment preparations pharmaceutical